Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
February 27 2024 - 4:30PM
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an
innovative life sciences technology company providing mission
critical automation solutions to facilitate the efficient
manufacturing and fast, safe release of healthcare products, today
announced that the Company will participate in the following
investor conferences:
-
TD Cowen 44th Annual
Healthcare Conference Question-and-answer session with the
host analyst on Tuesday, March 5, 2024, at 1:30 p.m. ET in Boston,
Massachusetts.
-
KeyBanc Life Sciences & MedTech Investor Forum
(Virtual)Question-and-answer session with the host analyst
on Tuesday, March 19, 2024, at 3:00 p.m. ET.
Live webcasts for both events will be available
on the Rapid Micro Biosystems investor relations website at
https://investors.rapidmicrobio.com/ and can be accessed here. The
webcasts will be archived and available for replay after the
event.
About Rapid Micro
Biosystems
Rapid Micro Biosystems is an innovative life
sciences technology company providing mission critical automation
solutions to facilitate the efficient manufacturing and fast, safe
release of healthcare products such as biologics, vaccines, cell
and gene therapies, and sterile injectables. The Company’s flagship
Growth Direct System automates and modernizes the antiquated,
manual microbial quality control (“MQC”) testing workflows used in
the largest and most complex pharmaceutical manufacturing
operations across the globe. The Growth Direct System brings the
quality control lab to the manufacturing floor, unlocking the power
of MQC automation to deliver the faster results, greater accuracy,
increased operational efficiency, better compliance with data
integrity regulations, and quicker decision making that customers
rely on to ensure safe and consistent supply of important
healthcare products. The Company is headquartered and has U.S.
manufacturing in Lowell, Massachusetts, with global locations in
Lexington, Massachusetts, Switzerland, Germany, and the
Netherlands. For more information, please
visit www.rapidmicrobio.com or follow the Company on
Twitter at @rapidmicrobio or on LinkedIn.
Investor Contact:
Michael Beaulieu, CFA
Vice President, Investor Relations and Corporate Communications
mbeaulieu@rapidmicrobio.com
Media Contact:
media@rapidmicrobio.com
Rapid Micro Biosystems (NASDAQ:RPID)
Historical Stock Chart
From Jun 2024 to Jul 2024
Rapid Micro Biosystems (NASDAQ:RPID)
Historical Stock Chart
From Jul 2023 to Jul 2024